Evidence map›Paper›PMID 40339151›Full record

ArticleSchizophrenia bulletin2025

Enhancing Coordinated Specialty Care Through Early Detection: Impact of Reduced Duration of Untreated Psychosis.

Hadar Hazan, Maria Ferrara, Bin Zhou, Fangyong Li, Shannon Imetovski, Laura A Yoviene Sykes, Jessica Pollard, John Cahill, Toni Gibbs-Dean, Silvia Corbera and 6 more

Abstract read
In one paragraph

Article in Schizophrenia bulletin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Hadar HazanProgram for Specialized Treatment Early in Psychosis (STEP), Department of Psychiatry, Yale University School of Medicine and Connecticut Mental Health Center (CMHC), New Haven, CT 06519, United States.
Maria FerraraProgram for Specialized Treatment Early in Psychosis (STEP), Department of Psychiatry, Yale University School of Medicine and Connecticut Mental Health Center (CMHC), New Haven, CT 06519, United States.ORCID 0000-0003-2143-1101
Bin ZhouYale Center for Analytical Sciences, New Haven, CT 06520-8034, United States.
Fangyong LiYale Center for Analytical Sciences, New Haven, CT 06520-8034, United States.
Shannon ImetovskiProgram for Specialized Treatment Early in Psychosis (STEP), Department of Psychiatry, Yale University School of Medicine and Connecticut Mental Health Center (CMHC), New Haven, CT 06519, United States.
Laura A Yoviene SykesProgram for Specialized Treatment Early in Psychosis (STEP), Department of Psychiatry, Yale University School of Medicine and Connecticut Mental Health Center (CMHC), New Haven, CT 06519, United States.ORCID 0000-0002-8863-6921
Jessica PollardNational Association of State Mental Health Program Directors (NASMHPD), Alexandria, VA 22314, United States.
John CahillProgram for Specialized Treatment Early in Psychosis (STEP), Department of Psychiatry, Yale University School of Medicine and Connecticut Mental Health Center (CMHC), New Haven, CT 06519, United States.
Toni Gibbs-DeanProgram for Specialized Treatment Early in Psychosis (STEP), Department of Psychiatry, Yale University School of Medicine and Connecticut Mental Health Center (CMHC), New Haven, CT 06519, United States.
Silvia CorberaDepartment of Psychological Science, Central Connecticut State University, New Britain, CT 06050, United States.
Sneha KarmaniProgram for Specialized Treatment Early in Psychosis (STEP), Department of Psychiatry, Yale University School of Medicine and Connecticut Mental Health Center (CMHC), New Haven, CT 06519, United States.
Sarah RileyProgram for Specialized Treatment Early in Psychosis (STEP), Department of Psychiatry, Yale University School of Medicine and Connecticut Mental Health Center (CMHC), New Haven, CT 06519, United States.
Sümeyra N TayfurProgram for Specialized Treatment Early in Psychosis (STEP), Department of Psychiatry, Yale University School of Medicine and Connecticut Mental Health Center (CMHC), New Haven, CT 06519, United States.
Cenk TekProgram for Specialized Treatment Early in Psychosis (STEP), Department of Psychiatry, Yale University School of Medicine and Connecticut Mental Health Center (CMHC), New Haven, CT 06519, United States.
Matcheri S KeshavanDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, United States.
Vinod H SrihariProgram for Specialized Treatment Early in Psychosis (STEP), Department of Psychiatry, Yale University School of Medicine and Connecticut Mental Health Center (CMHC), New Haven, CT 06519, United States.ORCID 0000-0003-1556-2332

Funding

STEP-ED:Reducing Duration of Untreated Psychosis and its Impact in the U.S.R01MH103831 · NIMH · YALE UNIVERSITY · PI SRIHARI, VINOD H. · 2013 to 2017
$3.9M
NIH HHS R01MH103831NIMH NIH HHS R01 MH103831
6 · The paper itself

Abstract

background and hypothesisEarly intervention can improve outcomes for individuals with first-episode psychosis (FEP). We hypothesized that an early detection campaign (ED) targeting the duration of untreated psychosis (DUP) can significantly improve functional outcomes in coordinated specialty care (CSC) patients. STUDY

designFunctional outcomes were compared for FEP patients enrolled from 2014 to 2019 in 2 CSCs: Specialized treatment early in psychosis (STEP), which implemented a 4-year ED campaign, and the prevention and recovery in early psychosis (PREP) clinic, which maintained usual detection practices. The relationship between DUP-Total (time from psychosis onset to CSC enrollment) with global assessment of functioning (GAF) and quality of life (QoL) scores at 6 and 12 months was assessed. Mediation analyses explored the contributions of DUP-Demand (time from psychosis onset to the first use of antipsychotic medication) and DUP-Supply (time from the first use of antipsychotic medication to CSC enrollment). STUDY

resultsShorter DUP-total was associated with higher GAF and QoL scores, particularly at 6 months. STEP patients showed significantly greater improvements in GAF (12.2 points higher at 6 months, P < .0001) and QoL (6.8 points higher at 6 months, P = .03) compared to PREP. Mediation analyses revealed that DUP-Supply, rather than DUP-Demand, was the primary driver of these improvements at 6 months, explaining 36% of the QoL difference between clinics.

conclusionsShorter DUP accelerates functional recovery, particularly in the first 6 months of CSC. Reducing DUP-Supply is critical for maximizing the benefits of early intervention. Streamlined referral and intake processes should be prioritized to enhance recovery outcomes.

Indexed as

Early DiagnosisEarly Medical InterventionOutcome Assessment, Health CarePsychotic DisordersQuality of LifeSchizophreniaTime-to-TreatmentAdolescentAdultAntipsychotic AgentsFemaleHumansMaleTime FactorsYoung AdultAntipsychotic Agentscoordinated specialty careduration of untreated psychosisearly detectionfirst-episode psychosisschizophrenia

Identifiers

PMID40339151
PMCPMC12597490

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.